Global /United States /Consumer Defensive /Household & Personal Products /KVUE
chevron_leftBack
Kenvue Inc. logo

Kenvue Inc.

KVUE
NYSE: KVUE Delayed
17.23USD -1.8%
As of 16 June 2026, Kenvue Inc. has a market cap of $33.08B USD, ranking #769 globally and #317 in the United States. It ranks #43 in the Consumer Defensive sector, and #10 in the Household & Personal Products industry.
Global Rank
769
Country Rank
317
Sector Rank
43
Industry Rank
10
Key Stats
Market Cap
$33.08BUSD
Enterprise Value
$40.56BUSD
Revenue (TTM)
$15.12BUSD
EBITDA (TTM)
$3.24BUSD
Net Income (TTM)
$1.47BUSD
EBITDA Margin
21%
Profit Margin
9.7%
PE Ratio
22.7
Forward PE
15.2
PS Ratio
2.2
PB Ratio
3.1
EV/EBITDA
12.5
Company Profile
Country (HQ)
Sector
Consumer Defensive
Industry
Household & Personal Products
CEO
Kirk Perry open_in_new
Employees
22,000
Founded
2022
IPO
04 May 2023
Website
kenvue.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-1.8% -0.5% -1.7% -0.6% 19% -25%

News

Loading...

KVUE Analyst Forecasts

Loading...

Markets

Exchange Ticker Price
NYSE
MIC: XNYS
PRIMARY
KVUE
Kenvue Inc
ISIN: US49177J1025
Shares Out.:
1.92B1 Shares Float: 1.917B2
TV:
SA:
YF:
GF:
NQ:
BA:
MS:
17.23 USD
Borsa Italiana
MIC: XMIL
1KVUE
Kenvue Inc
ISIN: US49177J1025
TV:
SA:
YF:
GF:
BA:
MS:
15.90 EUR
Frankfurt Stock Exchange
MIC: XFRA
J4D
Kenvue Inc
ISIN: US49177J1025
TV:
SA:
YF:
GF:
BA:
J4D
MS:
14.66 EUR
Show all 4 markets
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Kenvue Inc.

Kenvue Inc. operates as a consumer health company in the United States, rest of North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates in three segments: Self Care, Skin Health and Beauty, and Essential Health. The company offers over-the-counter medicine for cough, cold and allergy, pain care, digestive health, smoking cessation, and eye care, as well as other naturally inspired and self-care products, digital diagnostics, and telemedicine; face and body care, hair, sun, and other care products; oral and baby care, women’s health, wound care, and other essential health products; tampons; cosmetics; and vitamins and supplements. It sells its products under the Benadryl, Calpol, Motrin, Nicorette, Rhinocort, Tylenol, Zarbee’s Naturals, and Zyrtec; Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Neutrogena, OGX, and Rogaine; BAND-AID, Carefree, Desitin, Johnson’s, Listerine, o.b., and Stayfree; and ORSL, Clean & Clear, Versalie, Benylin, Daktarin, Imodium, Johnson’s Baby, Johnson’s Adult, Maui Moisture, Microlax, Motilium, Neosporin, Neostrata, Pepcid, Pulmicort, Regaine, Sudafed, and Visine/Vispring/Visclear brands. Kenvue Inc. was incorporated in 2022 and is headquartered in Summit, New Jersey.

Similar Companies

Industry: Household & Personal Products (United States)
Name
Market Cap diff.
PE
$341.05B
931%
21.8
$67.79B
105%
32.6
$47.73B
44%
19.6
KMB
$31.9B
-3.6%
15.1
$27.38B
-17%
-
$22.79B
-31%
32.1
Industry: Household & Personal Products (Global)
Name
Market Cap diff.
PE
OR
$231.29B
199.47B EUR
599%
32.7
ULVR
$124.75B
92.96B GBP
277%
18.7
$90.24B
77.83B EUR
173%
17.2
HINDUNILVR
$63.26B
5.98T INR
91%
53.8
$40.85B
30.44B GBP
23%
9.7
KER
$33.57B
28.95B EUR
1.5%
402.1
chevron_leftBack